راسبوریکاز (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "راسبوریکاز" in Persian language version.

refsWebsite

Global rank Persian rank

4^th place

5^th place

2^nd place

low place

7,927^th place

2,299^th place

102^nd place

515^th place

5^th place

12^th place

asnjournals.org

Wilson FP, Berns JS (October 2012). "Onco-nephrology: tumor lysis syndrome". Clin J Am Soc Nephrol. 7 (10): 1730–9. doi:10.2215/CJN.03150312. PMID 22879434. خطای یادکرد: برچسب <ref> نامعتبر؛ نام «Wilson2012» چندین بار با محتوای متفاوت تعریف شده است. (صفحهٔ راهنما را مطالعه کنید.).

Wilson FP, Berns JS (October 2012). "Onco-nephrology: tumor lysis syndrome". Clin J Am Soc Nephrol. 7 (10): 1730–9. doi:10.2215/CJN.03150312. PMID 22879434. خطای یادکرد: برچسب <ref> نامعتبر؛ نام «Wilson2012» چندین بار با محتوای متفاوت تعریف شده است. (صفحهٔ راهنما را مطالعه کنید.).
Ho VQ, Wetzstein GA, Patterson SG, Bradbury R (April 2006). "Abbreviated rasburicase dosing for the prevention and treatment of hyperuricemia in adults at risk for tumor lysis syndrome". Supportive Cancer Therapy. 3 (3): 178–82. doi:10.3816/SCT.2006.n.016. PMID 18632493.
Cheuk, Daniel Kl; Chiang, Alan Ks; Chan, Godfrey Cf; Ha, Shau Yin (8 March 2017). "Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer". The Cochrane Database of Systematic Reviews. 2017 (3): CD006945. doi:10.1002/14651858.CD006945.pub4. ISSN 1469-493X. PMC 6464610. PMID 28272834.
Cammalleri L, Malaguarnera M (2007). "Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout". International Journal of Medical Sciences. 4 (2): 83–93. doi:10.7150/ijms.4.83. PMC 1838823. PMID 17396159.
Lin, PY; et al. (2011), "Rasburicase improves hyperuricemia in patients with acute kidney injury secondary to rhabdomyolysis caused by ecstasy intoxication and exertional heat stroke", Pediatr Crit Care Med, 12 (6): e424–e427, doi:10.1097/PCC.0b013e3182192c8d, PMID 21572370.

World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

Wilson FP, Berns JS (October 2012). "Onco-nephrology: tumor lysis syndrome". Clin J Am Soc Nephrol. 7 (10): 1730–9. doi:10.2215/CJN.03150312. PMID 22879434. خطای یادکرد: برچسب <ref> نامعتبر؛ نام «Wilson2012» چندین بار با محتوای متفاوت تعریف شده است. (صفحهٔ راهنما را مطالعه کنید.).
Ho VQ, Wetzstein GA, Patterson SG, Bradbury R (April 2006). "Abbreviated rasburicase dosing for the prevention and treatment of hyperuricemia in adults at risk for tumor lysis syndrome". Supportive Cancer Therapy. 3 (3): 178–82. doi:10.3816/SCT.2006.n.016. PMID 18632493.
Cheuk, Daniel Kl; Chiang, Alan Ks; Chan, Godfrey Cf; Ha, Shau Yin (8 March 2017). "Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer". The Cochrane Database of Systematic Reviews. 2017 (3): CD006945. doi:10.1002/14651858.CD006945.pub4. ISSN 1469-493X. PMC 6464610. PMID 28272834.
Cammalleri L, Malaguarnera M (2007). "Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout". International Journal of Medical Sciences. 4 (2): 83–93. doi:10.7150/ijms.4.83. PMC 1838823. PMID 17396159.
Lin, PY; et al. (2011), "Rasburicase improves hyperuricemia in patients with acute kidney injury secondary to rhabdomyolysis caused by ecstasy intoxication and exertional heat stroke", Pediatr Crit Care Med, 12 (6): e424–e427, doi:10.1097/PCC.0b013e3182192c8d, PMID 21572370.

Cheuk, Daniel Kl; Chiang, Alan Ks; Chan, Godfrey Cf; Ha, Shau Yin (8 March 2017). "Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer". The Cochrane Database of Systematic Reviews. 2017 (3): CD006945. doi:10.1002/14651858.CD006945.pub4. ISSN 1469-493X. PMC 6464610. PMID 28272834.